Approval · Notice of Compliance 32432 · 2023
LONGRANGE: Notice of Compliance 32432
Issued December 27, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32432
- Date
- December 27, 2023
- Company
- Boehringer Ingelheim Animal Health Canada Inc.Burlington, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in the drug product manufacturing process
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LONGRANGE | Not yet assigned | — |
Medicinal ingredients
- EPRINOMECTIN 5 PER